You are here

  • Home
  • Archive
  • Volume 94, Issue 10
  • Decreased susceptibility to quinolones in methicillin-resistant Staphylococcus aureus isolated from ocular infections at a tertiary eye care centre

Article Text

Article menu
Download PDFPDF
PostScript
Letter
Decreased susceptibility to quinolones in methicillin-resistant Staphylococcus aureus isolated from ocular infections at a tertiary eye care centre
  1. B Bagga1,
  2. A K Reddy2,
  3. P Garg1
  1. 1Cornea and Anterior Segment Services, LV Prasad Eye Institute, Hyderabad, India
  2. 2Jhaveri Microbiology Centre, Prof Brien Holden Eye Research Centre, Hyderabad Eye Research Foundation, LV Prasad Eye Institute, Hyderabad, India
  1. Correspondence to Dr A K Reddy, Jhaveri Microbiology Centre, Hyderabad Eye Research Foundation, LV Prasad Eye Institute, Road No. 2 Banjara Hills, Hyderabad 500 034, India; ashokkumar{at}lvpei.org

https://doi.org/10.1136/bjo.2010.179747

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Methicillin-resistant Staphylococcus aureus (MRSA) is a serious cause of morbidity and mortality worldwide because of its multiple-drug resistance.1 In the past, MRSA infections were considered as hospital acquired; however, in the 1990s, serious MRSA infections were reported in patients with no previous contact with the healthcare system.2 Aggressive infections due to MRSA were observed in the eye and orbit in patients with no hospital exposure.3 There are very few reports on ocular MRSA infections, and to the best of our knowledge, there are no reports on MRSA in ocular infections from India. The present study was carried out to study the changing trends of methicillin susceptibility in S aureus isolated from different ocular infections and to analyse the susceptibility of MRSA to quinolones and vancomycin. …

    View Full Text